Long-acting injectable (LAI) is a revolutionary drug delivery system that addresses some of the most persistent challenges in treating chronic diseases. These include patient non-compliance in maintaining medication regimen, fluctuating drug levels in the plasma, need for frequent dosing, and more. By delivering therapeutic agents over extended periods, LAIs can significantly improve patient adherence, reduce adverse events, ensure targeted delivery, and enhance the quality of life.

This article delves into the various types of LAIs, technologies used, challenges in developing LAIs, and how leading CRO CDMO Syngene supports clients in bringing this delivery mode to patients efficiently and effectively.